Hemodialysis without heparin
Romão Júnior, J.E.; Fadil, M.A.; Zeratti, A.D.; Sabbaga, E.
Revista do Hospital das Clinicas 38(2): 70-72
1983
ISSN/ISBN: 0041-8781 PMID: 6648231 Document Number: 210914
Document emailed within 1 workday
Related Documents
Pelayo Alonso, R.; Cobo Sánchez, J.L.; de Buruaga Perea, A.S.áe.; Menezo Viadero, R.; Gándara Revuelta, M.; Aja Crespo, A.; Tovar Rincón, A. 2013: Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems Revista de Enfermeria 36(3): 8-12Simons, O. 1984: Heparin activity during hemodialysis Clinical Nephrology 21(4): 247
Buccianti, G.; Pogliani, E.; Lorenz, M.; Cofrancesco, E.; Bianchi, M.L.; Cresseri, D.; Valenti, G. 1985: Heparin dosage during hemodialysis Journal of Laboratory and Clinical Medicine 105(1): 139-140
Pittard, J.D. 2001: Heparin therapy in routine hemodialysis Nephrology News and Issues 15(5): 73-75
Janczak, D.; Pupka, A.; Skóra, J.; Szyber, P.ła.; Czapla, B.ło. 2010: The use of the heparin-bonded ePTFE grafts for needs of the hemodialysis Polimery W Medycynie 40(4): 35-39
Pristautz, H.; Katschnig, H.; Schenk, H.; Steinberger, R.; Pogglitsch, H.; Sailer, S. 1979: Effect of various parameters on heparin utilization in short-term hemodialysis Die Medizinische Welt 30(49): 1846-1848
Gavranić, B.B.; Basić-Jukić, N.; Kes, P. 2012: Patient who developed heparin-induced thrombocytopenia type Ii after 24 years on hemodialysis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 66(Suppl 2): 68-71
Buccianti, G.; Valenti, G.; Lorenz, M.; Cresseri, D.; Strada, E.; Nazzari, M. 1990: Kinetics of anti-Xa activity during combined defibrotide-heparin administration in hemodialysis International Journal of Artificial Organs 13(7): 416-420
Henríquez, F.; Rodríguez, A.; Mora, C.; Sánchez-Deig, E.; Macía, M.; Navarro, J. 2006: Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 26(6): 734-737
Matsuo, T.; Matsuo, M.; Ouga-Maruyama, S. 2001: Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)? Thrombosis and Haemostasis 86(4): 1115-1116
Benítez, M.; González Gómez, I.; González Carmelo, I.; Palma, A.; Cruz, S.; Rodríguez, E.; Amián, A.; Fernández M, F.; Merino, M.J.; Fernández G, F.; Suárez, C.; Onaindía, J.M.; González, J. 2007: Heparin immune thrombocytopenia in a hemodialysis patient. A case report. Literature review Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(6): 756-760
Eastwood, J.B.; Phillips, M.E.; Minty, P.; Gower, P.E.; Curtis, J.R. 1983: Heparin inactivation, acidosis and copper poisoning due to presumed acid contamination of water in a hemodialysis unit Clinical Nephrology 20(4): 197-201
Leu, J.G.; Liou, H.H.; Wu, S.C.; Yang, W.C.; Huang, T.P.; Wu, S.C. 1998: Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis Journal of the Formosan Medical Association 97(1): 49-54
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Knudsen, F.; Kristensen, S.D.; Nielsen, A.H.; Ring, T.; Stoffersen, E. 1985: Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction? Clinical Nephrology 23(2): 107
Melissari, E.; Thye, C.; Scully, M.F.; Kakkar, V.V. 1989: Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells Thrombosis and Haemostasis 61(2): 262-265
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Kudriashov, B.A.; Liapina, L.A.; Molchanova, L.V.; Rustamova, B.A. 1970: Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin Voprosy Meditsinskoi Khimii 16(2): 161-168
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Zimmermann, R.E.; Schwering, H.; Wittrin, G.; Hollenders, T. 1981: Control of low-dose heparin therapy using photometry to detect biologically active heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(5): 316-319